ELITE PHARMACEUTICALS INC /NV/ Quarterly Interest Expense in USD from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q1 2024.
  • Elite Pharmaceuticals Inc /Nv/ Interest Expense for the quarter ending March 31, 2024 was $217K, a 34.3% decline year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ Interest Expense for the twelve months ending March 31, 2024 was $589K, a 47.1% decline year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ annual Interest Expense for 2023 was $589K, a 47.1% decline from 2022.
  • Elite Pharmaceuticals Inc /Nv/ annual Interest Expense for 2022 was $1.11M, a 480% increase from 2021.
  • Elite Pharmaceuticals Inc /Nv/ annual Interest Expense for 2021 was $192K, a 26.1% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $589K $217K -$113K -34.3% Jan 1, 2024 Mar 31, 2024 10-K 2024-07-01
Q4 2023 $702K $122K -$201K -62.3% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $903K $130K -$112K -46.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.02M $119K -$97.4K -44.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.11M $330K +$265K +405% Jan 1, 2023 Mar 31, 2023 10-K 2024-07-01
Q4 2022 $848K $323K +$285K +763% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 $562K $243K +$200K +463% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $363K $217K +$171K +372% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $192K $65.4K +$44.7K +216% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-29
Q4 2021 $147K $37.4K -$42.3K -53.1% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 $189K $43.1K -$36.7K -46% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $226K $45.9K -$33.5K -42.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $260K $20.7K -$51.5K -71.3% Jan 1, 2021 Mar 31, 2021 10-K 2022-06-29
Q4 2020 $311K $79.7K -$14.8K -15.7% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $326K $79.8K -$11.7K -12.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $338K $79.4K -$18.2K -18.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $356K $72.2K -$17.9K -19.9% Jan 1, 2020 Mar 31, 2020 10-K 2021-06-14
Q4 2019 $374K $94.5K +$4.62K +5.14% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 $369K $91.5K -$14.5K -13.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $384K $97.7K +$14.5K +17.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $369K $90.1K +$368 +0.41% Jan 1, 2019 Mar 31, 2019 10-K 2020-06-30
Q4 2018 $369K $89.9K -$2.56K -2.77% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 $371K $106K +$23.5K +28.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $348K $83.1K +$12.4K +17.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $335K $89.8K +$33.4K +59.3% Jan 1, 2018 Mar 31, 2018 10-K 2019-06-21
Q4 2017 $302K $92.5K +$36.9K +66.4% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-11
Q3 2017 $265K $82.5K +$25.2K +43.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $240K $70.7K +$1.79K +2.59% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $238K $56.3K -$16.2K -22.3% Jan 1, 2017 Mar 31, 2017 10-K 2018-06-14
Q4 2016 $254K $55.6K -$12.6K -18.4% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 $267K $57.4K -$6.45K -10.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $273K $68.9K -$7.29K -9.56% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $281K $72.5K -$299 -0.41% Jan 1, 2016 Mar 31, 2016 10-K 2018-06-14
Q4 2015 $281K $68.1K +$1.97K +2.97% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 $279K $63.8K -$6.25K -8.92% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $285K $76.2K -$1.98K -2.53% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $287K $72.8K -$96.7K -57% Jan 1, 2015 Mar 31, 2015 10-K 2017-06-14
Q4 2014 $384K $66.2K -$293K -81.6% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $677K $70.1K -$186K -72.6% Jul 1, 2014 Sep 30, 2014 10-Q/A 2015-12-30
Q2 2014 $863K $78.2K +$3.43K +4.58% Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-12-30
Q1 2014 $859K $169K +$99.4K +142% Jan 1, 2014 Mar 31, 2014 10-K 2016-06-15
Q4 2013 $760K $359K +$295K +462% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 $465K $256K +$195K +318% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $270K $74.8K +$16.2K +27.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $254K $70K +$12.9K +22.5% Jan 1, 2013 Mar 31, 2013 10-K 2014-06-30
Q4 2012 $241K $63.9K +$6.79K +11.9% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 $234K $61.2K +$3.32K +5.72% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $231K $58.5K +$1.17K +2.04% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $230K $57.2K -$117K -67.2% Jan 1, 2012 Mar 31, 2012 10-K 2013-06-21
Q4 2011 $346K $57.1K -$921 -1.59% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-14
Q3 2011 $347K $57.9K +$194 +0.34% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $347K $57.4K +$115K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $232K $174K Jan 1, 2011 Mar 31, 2011 10-K 2012-06-29
Q4 2010 $58.1K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 $57.7K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$58.1K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.